Healios K.K.
TSE:4593.T
241 (JPY) • At close September 19, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) JPY.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 121 | 90 | 41 | 27 | 89 | 0 | 27.666 | 77.64 | 98.167 | 279.997 |
| Cost of Revenue
| 386 | 0 | 0 | 0 | 69 | 78 | 3.319 | 9.145 | 9.392 | 49.231 |
| Gross Profit
| -265 | 90 | 41 | 27 | 20 | -78 | 24.347 | 68.495 | 88.775 | 230.766 |
| Gross Profit Ratio
| -2.19 | 1 | 1 | 1 | 0.225 | 0 | 0.88 | 0.882 | 0.904 | 0.824 |
| Reseach & Development Expenses
| 2,304 | 3,808 | 3,700 | 2,986 | 3,217 | 4,269 | 1,730.363 | 2,959.616 | 629.1 | 327.06 |
| General & Administrative Expenses
| 1,184 | 1,449 | 1,722 | 1,239 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling & Marketing Expenses
| -373 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 811 | 1,449 | 1,722 | 1,239 | 1,014 | 716 | 541.875 | 447.033 | 356.622 | 804 |
| Other Expenses
| 0 | 12 | 3 | -14 | 1,053 | 794 | 2.87 | 116.838 | 137.689 | 99.182 |
| Operating Expenses
| 3,115 | 5,269 | 5,425 | 4,211 | 4,270 | 5,063 | 2,372.554 | 3,575.959 | 1,149.19 | 799.061 |
| Operating Income
| -3,380 | -5,179 | -5,384 | -4,184 | -4,271 | -5,063 | -2,348.208 | -3,507.464 | -1,060.416 | -568.296 |
| Operating Income Ratio
| -27.934 | -57.544 | -131.317 | -154.963 | -47.989 | 0 | -84.877 | -45.176 | -10.802 | -2.03 |
| Total Other Income Expenses Net
| -248 | -151 | 922 | -1,194 | -132 | -28 | 576.658 | 80.723 | 102.288 | 97.731 |
| Income Before Tax
| -3,628 | -5,330 | -4,462 | -5,378 | -4,403 | -5,091 | -1,771.55 | -3,426.741 | -958.128 | -470.564 |
| Income Before Tax Ratio
| -29.983 | -59.222 | -108.829 | -199.185 | -49.472 | 0 | -64.033 | -44.136 | -9.76 | -1.681 |
| Income Tax Expense
| 187 | -160 | 450 | 135 | 6 | 5 | 5.102 | 6.813 | -0.025 | 6.693 |
| Net Income
| -3,823 | -5,170 | -4,912 | -5,513 | -4,409 | -5,097 | -1,776.653 | -3,433.554 | -958.103 | -477.258 |
| Net Income Ratio
| -31.595 | -57.444 | -119.805 | -204.185 | -49.539 | 0 | -64.218 | -44.224 | -9.76 | -1.705 |
| EPS
| -56.22 | -90.69 | -93.4 | -107.21 | -87.94 | -103.52 | -39.73 | -84.33 | -25.6 | -14.17 |
| EPS Diluted
| -56.22 | -90.69 | -93.4 | -107.21 | -87.94 | -103.52 | -39.73 | -84.33 | -25.6 | -12.01 |
| EBITDA
| -3,007 | -4,444 | -3,398 | -3,967 | -4,400 | -5,006 | -2,313.069 | -3,257.883 | -961.245 | -469.42 |
| EBITDA Ratio
| -24.851 | -49.378 | -82.878 | -146.926 | -49.438 | 0 | -83.607 | -41.961 | -9.792 | -1.677 |